Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial
- PMID: 11317091
- DOI: 10.1097/00005650-200105000-00003
Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial
Abstract
Context: Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most frequently prescribed drugs for patients 65 years of age or older, primarily for musculoskeletal symptoms of osteoarthritis. Because NSAIDs frequently cause serious gastrointestinal (GI) and other complications among elderly patients, expert guidelines for osteoarthritis recommend acetaminophen-based regimens, which are safer and often as effective as NSAIDs.
Objective: Evaluate a physician education program that communicated guidelines for management of osteoarthritis in elderly patients that emphasized avoidance of NSAIDs when possible. The program reviewed NSAID risks and benefits and recommended: re-evaluating continuous NSAID users, considering substitution of up to 4 g/d of acetaminophen for the NSAID, and trying topical agents and nonpharmacologic measures.
Design and setting: Randomized controlled trial among community-dwelling Tennessee Medicaid enrollees.
Subjects: Study physicians had 5 or more patients who: were community-dwelling Medicaid enrollees 65 years of age or older; had used NSAIDs regularly for at least 180 days; had had no medical care encounters during this period suggesting an indication other than osteoarthritis; and had 1 year of baseline and follow-up data. The study thus included 209 physicians (103 intervention/106 control) with 1,566 qualifying regular NSAID users (768/798).
Interventions: Face-to-face visit to study physicians by another physician, and reminder placements in the charts of patients eligible to have NSAID use reevaluated.
Outcomes: Change between baseline and follow-up years in: days of prescribed NSAIDs, acetaminophen, other drugs for musculoskeletal disorders, and GI drugs; outpatient visits and inpatient days of stay; SF36 measures of general health, physical function, and bodily pain (from 40% random patient sample); and over-the-counter NSAIDs (from the sample).
Results: Intervention-attributable reduction of 7% (95% CI, 3% to 11%) in days of prescribed NSAIDs use with concomitant increase in acetaminophen use. No significant changes in other study endpoints. The intervention effect was greater among 75 physicians with a completed study visit, whose 564 patients had a 10% (95% CI, 6% to 14%) attributable reduction in NSAID use.
Conclusions: The educational program modestly reduced NSAID exposure in community-dwelling elderly patients without undesirable substitution of other medications or detectable worsening of musculoskeletal symptoms.
Comment in
-
NSAID reduction through alternative pain-management programs.Med Care. 2001 Dec;39(12):1352-3. doi: 10.1097/00005650-200112000-00011. Med Care. 2001. PMID: 11717577 No abstract available.
Similar articles
-
Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial.Med Care. 2001 May;39(5):436-45. doi: 10.1097/00005650-200105000-00004. Med Care. 2001. PMID: 11317092 Clinical Trial.
-
Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.Clin Drug Investig. 2008;28(11):687-95. doi: 10.2165/00044011-200828110-00002. Clin Drug Investig. 2008. PMID: 18840011
-
Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.Am J Manag Care. 2004 Nov;10(11 Pt 1):742-50. Am J Manag Care. 2004. PMID: 15623264
-
Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.Am J Med. 1998 Mar 30;104(3A):23S-29S; discussion 41S-42S. doi: 10.1016/s0002-9343(97)00207-6. Am J Med. 1998. PMID: 9572317 Review.
-
Acetaminophen for osteoarthritis.Cochrane Database Syst Rev. 2003;(2):CD004257. doi: 10.1002/14651858.CD004257. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004257. doi: 10.1002/14651858.CD004257.pub2. PMID: 12804508 Updated. Review.
Cited by
-
Scoping review of interventions to de-implement potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) in healthcare settings.BMJ Open. 2024 Apr 17;14(4):e078808. doi: 10.1136/bmjopen-2023-078808. BMJ Open. 2024. PMID: 38631836 Free PMC article. Review.
-
Reporting of costs and economic impacts in randomized trials of de-implementation interventions for low-value care: a systematic scoping review.Implement Sci. 2023 Aug 21;18(1):36. doi: 10.1186/s13012-023-01290-3. Implement Sci. 2023. PMID: 37605243 Free PMC article. Review.
-
Manually-generated reminders delivered on paper: effects on professional practice and patient outcomes.Cochrane Database Syst Rev. 2019 Dec 18;12(12):CD001174. doi: 10.1002/14651858.CD001174.pub4. Cochrane Database Syst Rev. 2019. PMID: 31858588 Free PMC article.
-
Knowledge of patients on safe medication use in relation to nonsteroidal anti-inflammatory drugs.Saudi J Anaesth. 2019 Apr-Jun;13(2):106-111. doi: 10.4103/sja.SJA_557_18. Saudi J Anaesth. 2019. PMID: 31007655 Free PMC article.
-
International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G.Euroasian J Hepatogastroenterol. 2018 Jul-Dec;8(2):148-160. doi: 10.5005/jp-journals-10018-1281. Epub 2019 Feb 1. Euroasian J Hepatogastroenterol. 2018. PMID: 30828557 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
